MDWD
MediWound Ltd. NASDAQ Listed Mar 20, 2014$13.94
+4.73%
vs $13.31
Mkt Cap $179.1M
52w Low $12.52
18.9% of range
52w High $20.03
50d MA $13.73
200d MA $16.04
P/E (TTM)
—
EV/EBITDA
—
P/B
3.0x
Debt/Equity
0.2x
ROE
—
P/FCF
-7.6x
RSI (14)
59.60
ATR (14)
$0.51
Beta
0.15
50d MA
$13.73
200d MA
$16.04
Avg Volume
103.3K
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
42 Hayarkon Street · Yavne, L3 8122745 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | BMO | -0.76 | -0.77 | -1.1% | 13.91 | +1.1% | -2.7% | +0.2% | -1.3% | +1.9% | -0.4% | — |
| May 27, 2026 | BMO | -0.65 | -0.23 | +64.6% | 16.68 | -5.3% | -14.1% | +1.6% | -1.6% | -3.6% | -0.4% | — |
| Mar 5, 2026 | BMO | -0.65 | -0.56 | +13.8% | 17.45 | -1.0% | -2.4% | +2.7% | -0.7% | -0.9% | -3.7% | — |
| Nov 20, 2025 | BMO | -0.81 | -0.24 | +70.4% | 16.86 | +1.8% | +1.2% | +6.2% | +0.4% | -1.2% | -0.4% | — |
| Aug 14, 2025 | BMO | -0.55 | -1.23 | -123.6% | 18.57 | +0.6% | -2.5% | -2.8% | -1.4% | +0.5% | -0.3% | — |
| May 21, 2025 | BMO | -0.65 | -0.07 | +89.2% | 19.89 | +0.5% | +2.3% | +0.1% | +4.7% | -1.1% | +1.2% | — |
| Mar 19, 2025 | BMO | -0.59 | -0.36 | +39.0% | 18.28 | -1.0% | -6.7% | -4.6% | +1.1% | +1.3% | -0.8% | — |
| Nov 26, 2024 | BMO | -0.44 | -0.98 | -122.7% | 16.90 | -0.6% | +3.3% | +0.1% | +3.6% | +1.8% | -2.1% | — |
| Aug 14, 2024 | BMO | -0.42 | -0.68 | -61.9% | 17.47 | +3.3% | +4.0% | +6.1% | -0.5% | -1.7% | -0.6% | — |
| May 29, 2024 | BMO | -0.40 | -0.39 | +2.5% | 16.01 | +1.2% | +0.2% | +1.7% | +1.2% | +2.9% | +0.1% | — |
| Mar 21, 2024 | BMO | -0.23 | -0.19 | +17.4% | 15.95 | +0.3% | +0.1% | -0.9% | -1.7% | -3.0% | -5.6% | — |
| Nov 21, 2023 | BMO | -0.44 | -0.24 | +45.5% | 8.40 | -2.1% | +3.6% | -1.3% | -0.3% | -0.7% | +3.5% | — |
| Aug 15, 2023 | BMO | -0.40 | 0.10 | +125.0% | 9.06 | +4.7% | -1.5% | -1.9% | -2.1% | +4.9% | +0.8% | — |
| May 30, 2023 | AMC | -0.30 | -0.44 | -46.7% | 8.99 | -1.2% | +1.6% | -1.9% | -0.6% | +3.8% | +4.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.86 | $17.16 | +1.8% | +1.2% | +6.2% | +0.4% | -1.2% | -0.4% |
| May 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $19.89 | $19.99 | +0.5% | +2.3% | +0.1% | +4.7% | -1.1% | +1.2% |
| Mar 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $18.28 | $18.10 | -1.0% | -6.7% | -4.6% | +1.1% | +1.3% | -0.8% |
| Jan 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.01 | $16.05 | +0.2% | +4.4% | +9.4% | +4.0% | +1.4% | -5.8% |
| Nov 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.90 | $16.80 | -0.6% | +3.3% | +0.1% | +3.6% | +1.8% | -2.1% |
| Oct 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.75 | $16.86 | +0.7% | +0.4% | +6.3% | -4.4% | +5.2% | +0.8% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $17.47 | $18.05 | +3.3% | +4.0% | +6.1% | -0.5% | -1.7% | -0.6% |
| Jul 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.41 | $21.02 | +3.0% | +1.9% | -2.2% | +2.8% | -11.0% | +3.2% |
| May 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.01 | $16.21 | +1.2% | +0.2% | +1.7% | +1.2% | +2.9% | +0.1% |
| Mar 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $15.95 | $16.00 | +0.3% | +0.1% | -0.9% | -1.7% | -3.0% | -5.6% |
| Jan 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.65 | $12.90 | +2.0% | +1.7% | +0.6% | +0.5% | -0.2% | +3.8% |
| Nov 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.40 | $8.22 | -2.1% | +3.6% | -1.3% | -0.3% | -0.7% | +3.5% |
| Sep 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.05 | $9.54 | +5.4% | +1.2% | -1.5% | -4.9% | +2.9% | +4.2% |
| Aug 17 | Oppenheimer | Maintains | Outperform → Outperform | — | $8.92 | $8.90 | -0.2% | -1.9% | -2.1% | +4.9% | +0.8% | -2.0% |
| Aug 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.92 | $8.90 | -0.2% | -1.9% | -2.1% | +4.9% | +0.8% | -2.0% |
| May 31 | Oppenheimer | Maintains | Outperform → Outperform | — | $8.99 | $8.88 | -1.2% | +1.6% | -1.9% | -0.6% | +3.8% | +4.9% |
| May 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.99 | $8.88 | -1.2% | +1.6% | -1.9% | -0.6% | +3.8% | +4.9% |
| Mar 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.65 | $10.45 | -1.9% | +2.6% | -0.1% | +4.2% | +3.6% | -2.8% |
| Jan 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.29 | $12.98 | -2.3% | -1.7% | -3.2% | -0.1% | -0.6% | -1.2% |
| Dec 30 | TD Cowen | Maintains | Outperform → Outperform | — | $13.38 | $13.34 | -0.3% | +0.8% | -1.5% | -1.7% | -3.2% | -0.1% |
| Dec 22 | Maxim Group | Maintains | Buy → Buy | — | $11.00 | $11.31 | +2.8% | -0.5% | +5.0% | +0.5% | +11.3% | +4.0% |
| Dec 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $11.04 | $12.00 | +8.7% | -0.4% | -0.5% | +5.0% | +0.5% | +11.3% |
| Nov 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.69 | $11.41 | -2.4% | -10.8% | -2.7% | +2.1% | +2.0% | +4.0% |
| May 18 | Wells Fargo | Maintains | Overweight → Overweight | — | $12.39 | $12.81 | +3.4% | +2.3% | -0.6% | +0.9% | +0.8% | -5.5% |
| Mar 21 | Aegis Capital | Maintains | Buy → Buy | — | $13.72 | $14.00 | +2.0% | -1.5% | +0.5% | +0.0% | +1.0% | -1.5% |
| Aug 17 | Aegis Capital | Maintains | Buy → Buy | — | $24.01 | $23.87 | -0.6% | -0.6% | +2.3% | -1.1% | +2.3% | +0.6% |
| Aug 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.60 | $26.88 | +1.1% | -7.1% | +2.0% | -2.2% | -2.6% | -0.6% |
| Mar 2 | Aegis Capital | Maintains | Buy → Buy | — | $38.36 | $38.22 | -0.4% | -6.2% | +7.6% | -6.1% | -3.3% | +5.6% |
| Sep 23 | BTIG | Maintains | Buy → Buy | — | $25.06 | $25.62 | +2.2% | +3.6% | -1.3% | +1.4% | +0.0% | +3.5% |
| Aug 5 | H.C. Wainwright | Maintains | Buy → Buy | — | $18.06 | $17.84 | -1.2% | +12.0% | +1.0% | +2.7% | +4.7% | +1.6% |
| Mar 20 | Wells Fargo | Maintains | Outperform → Outperform | — | $32.72 | $34.65 | +5.9% | +15.5% | +0.9% | +0.9% | -4.5% | +0.0% |
| Mar 20 | Oppenheimer | Maintains | Outperform → Outperform | — | $32.72 | $34.65 | +5.9% | +15.5% | +0.9% | +0.9% | -4.5% | +0.0% |
| Sep 28 | TD Cowen | Maintains | Outperform → Outperform | — | $34.30 | $35.00 | +2.0% | +2.0% | +7.0% | -3.3% | +0.5% | -2.9% |
| Nov 28 | Aegis Capital | Maintains | Buy → Buy | — | $36.75 | $37.10 | +1.0% | +1.9% | +0.0% | +0.0% | +0.0% | -1.9% |
| Aug 17 | Wells Fargo | Maintains | Outperform → Outperform | — | $44.59 | $47.46 | +6.4% | +23.4% | +1.9% | +2.5% | -0.6% | -2.2% |
| Jul 29 | Jefferies | Maintains | Buy → Buy | — | $53.90 | $53.34 | -1.0% | -4.0% | -2.4% | -6.8% | +8.5% | +0.8% |
| Mar 23 | SunTrust Robinson Humphrey | Maintains | Buy → Buy | — | $52.94 | $52.71 | -0.4% | +1.2% | -0.9% | +1.1% | +3.0% | +1.3% |
| Feb 3 | Jefferies | Maintains | Buy → Buy | — | $42.35 | $45.57 | +7.6% | +17.4% | +1.8% | -2.6% | -4.4% | -1.5% |
| Jan 11 | Brean Capital | Maintains | Buy → Buy | — | $60.20 | $63.56 | +5.6% | -6.0% | +2.8% | -3.7% | +3.5% | -8.5% |
| Jan 8 | Brean Capital | Maintains | Buy → Buy | — | $62.79 | $62.44 | -0.6% | -4.1% | -6.0% | +2.8% | -3.7% | +3.5% |
| Feb 13 | Jefferies | Maintains | Buy → Buy | — | $49.31 | $49.21 | -0.2% | +2.5% | +3.2% | +2.0% | +0.1% | -1.2% |
| Apr 16 | Oppenheimer | Maintains | Outperform → Outperform | — | $82.32 | $85.40 | +3.7% | +7.1% | +2.0% | -0.9% | -3.8% | -5.9% |
| Apr 14 | BMO Capital | Maintains | Outperform → Outperform | — | $81.97 | $84.35 | +2.9% | +4.1% | -3.5% | +7.1% | +2.0% | -0.9% |
| Apr 14 | Jefferies | Maintains | Buy → Buy | — | $81.97 | $84.35 | +2.9% | +4.1% | -3.5% | +7.1% | +2.0% | -0.9% |
| Apr 14 | Credit Suisse | Maintains | Outperform → Outperform | — | $81.97 | $84.35 | +2.9% | +4.1% | -3.5% | +7.1% | +2.0% | -0.9% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | SHAMIR NACHUMDir | — | Buy | 5,825 | $14.00 | $82K | 55,815 | -1.87% | +1.66% |
| Jun 3, 2026 | SHAMIR NACHUMDir | — | Buy | 175 | $13.97 | $2K | 49,990 | -1.87% | +1.66% |
| Jun 1, 2026 | Fox David MortonDir | — | Buy | 1,797 | $13.99 | $25K | 22,283 | -0.22% | +0.63% |
| Jun 1, 2026 | Fox David MortonDir | — | Buy | 10 | $14.23 | $142 | 20,486 | -0.22% | +0.63% |
| Jun 1, 2026 | Fox David MortonDir | — | Buy | 1,730 | $14.22 | $25K | 20,476 | -0.22% | +0.63% |
| May 29, 2026 | Rubinstein SamuelDir | — | Buy | 150 | $14.33 | $2K | 2,993 | -0.43% | +0.21% |
No recent filings available.
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 7
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | ARK Israel Innovative Technology ETF | 129,961 | $2M | Jan 2026 |
| 2 | Small Cap Index Fund | 5,369 | $79K | Jun 2026 |
| 3 | Penn Series Small Cap Index Fund | 200 | $3K | Mar 2026 |
| 4 | Avantis Total Equity Markets ETF | 24 | $415 | Feb 2026 |
| 5 | Russell 2000 Fund | 18 | $290 | Mar 2026 |
| 6 | Russell 2000 1.5x Strategy Fund | 11 | $177 | Mar 2026 |
| 7 | Russell 2000(R) 1.5x Strategy Fund | 3 | $44 | Jun 2026 |
Valuation
Market Cap
$179.1M
Enterprise Value
$98.3M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.29x
P/B
3.05x
P/S
13.37x
P/FCF
-7.56x
EV/EBITDA
—
Shares Out
11.4M
Financials (TTM)
Revenue
$11.9M
Net Income
-$20.2M
EBITDA
-$19.0M
Free Cash Flow
-$20.0M
Op Cash Flow
-$14.5M
EPS Basic
$-2.10
EPS Diluted
$-1.60
EPS Forward
$-2.75
Gross Margin
15.5%
Op Margin
-267.9%
Net Margin
-170.1%
Balance Sheet
Total Assets
$86.3M
Total Liab.
$34.3M
Total Equity
$43.6M
Cash
$53.1M
LT Debt
$0
Book Value/Sh
$4.56
Debt/Equity
0.20x
Current Ratio
2.33
Quick Ratio
2.17
Returns & Growth
ROE
—
ROA
—
ROIC
-41.3%
Rev Growth YoY
-16.1%
EPS Growth YoY
+30.7%
Price Returns
2W
+0.2%
1M
+0.8%
3M
-4.7%
6M
-21.5%
12M
-25.8%
Technicals
52W High
$20.03
52W Low
$12.52
50d MA
$13.73
200d MA
$16.04
RSI (14)
59.60
ATR (14)
$0.51
Beta
0.15
Avg Volume
103K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$36.00
High
$36.00
Low
$36.00
Median
$36.00
Data updated apr 26, 2026 11:44am
· Source: financialmodelingprep.com